(Q43741093)

26 November 2017

title

Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: A systemic, splanchnic and renal hemodynamic study (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

25 October 2022

1 reference

A. Hadengue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

R. Moreau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

Y. Bacq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

C. Gaudin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

A. Braillon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

D. Lebrec

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671029

25 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

full work available at URL

26 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840130116

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840130116

25 October 2022

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

25 October 2022

1 reference

26 November 2017

volume

13

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

111-116

1 reference

The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

Pathophysiology of ascites and functional renal failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Response to Dopamine Hydrochloride in the Hepatorenal Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Dopamine in the Hepatorenal Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Effect of Dopamine on Hepatosplanchnic Blood Flow

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

A new oral renal vasodilator, fenoldopam

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

The sympathetic nervous system and renal sodium handling: is dopamine involved?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

The renal response to low dose dopamine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130116

7 January 2021

Vienna Clinical Weekly

6

90

3

Peschl

1978

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

25 October 2022

16

21

43

Caesar

1961

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

American Journal of Physiology

25 October 2022

17

247

e13

Hjemdahl

1984

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

American Journal of Physiology

25 October 2022

19

246

f557

Felder

1984

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130116

25 October 2022

Identifiers

1 reference

26 November 2017

1 reference